Jacqui Wise London

A study of a chemotherapy-free targeted regimen for colorectal cancer published recently in the New England Journal of Medicine has been denounced as the “single worst reported randomised controlled trial.”

Vinay Prasad, a practising haematologist-oncologist and associate professor of medicine at Oregon Health and Science University in Portland, Oregon, harshly criticised the BEACON study on Twitter and in the podcast Plenary Session for failing to provide basic information and for numerous redactions in the original published protocol.1